Happening tomorrow!
We're looking forward to seeing you at the Optimal Care Pathway for Lung Cancer in an Evolving Field Workshop.
Registrations/lunch from 12:00pm.
29.07.2025 05:54 β π 2 π 1 π¬ 0 π 0
One week until the inaugural #ESMOTATAsia25 π€©
I'm looking forward to joining global drug development experts inπππ°
+ sharing insights on dose optimisation of novel combinations
ποΈ Saturday 19 July 2pm.
@myesmo.bsky.social @herbloongmd.bsky.social @anmwongnz.bsky.social
11.07.2025 19:36 β π 6 π 2 π¬ 0 π 0
Challenging Cases in Immunotherapy Related Organ Toxicities
This is a book that focuses on examples of challenging cases with toxicities presented in different organ systems
π Just launched: the first-ever clinical casebook focused solely on immune-related toxicities. 65 expert-contributed cases across 10+ organ systems. Essential reading for the #irAE frontlines. Grab your copy π link.springer.com/book/10.1007...
#irAE #OncologyBooks @ascocancer.bsky.social #ASPIRE
27.06.2025 00:01 β π 2 π 1 π¬ 0 π 0
Was chatting to my registrar about transitioning to life as a new consultant
π€©remembered @theracp.bsky.social has a handbook on this!
www.racp.edu.au/docs/default...
What are your top tips?
#MedEd #Newfaculty
24.06.2025 09:41 β π 0 π 0 π¬ 0 π 0
ASPIRE MEMBERSHIP FORM
To unite the global medical community to advance clinical practice, education, and research in the prevention, diagnosis, and management of immune-related adverse events (irAEs) from immunomodulating ...
π That's a wrap #ASCO25! Join ASCOβs #ASPIRE Community of Practice, the go-to hub for clinicians addressing immune-related toxicities!
π FREE access for non-oncologists (for a limited time)
π¬ Engage in virtual meetings, expert discussions, and access curated content!
docs.google.com/forms/d/1zfl...
03.06.2025 13:16 β π 6 π 3 π¬ 0 π 0
Starting soon! More great #irAE content at #ASCO25, including CAR-T and BiTES @kmittalmd.bsky.social @funchainmd.bsky.social @kerryreynoldsmd.bsky.social #ASPIRE
01.06.2025 21:29 β π 4 π 3 π¬ 0 π 0
Such important work @aspire-cop.bsky.social team. Crucial to collect the right info to improve our understanding of immunotherapy toxicities and plan the right supportive care for our patients
#IOtox #supportivecare #immunotherapy
30.05.2025 23:52 β π 0 π 1 π¬ 0 π 0
Did you know the ICD10 codes to identify patients experiencing immunotherapy toxicity? @kmittalmd.bsky.social presents these codes as a system-based approach to capture #irAE impact @funchainmd.bsky.social @kerryreynoldsmd.bsky.social @mazietsangmd.bsky.social @ascocancer.bsky.social
30.05.2025 18:32 β π 7 π 5 π¬ 0 π 1
πCalling all #ASCO25 presenters!π Are you showcasing an #irAE poster? #ASPIRE wants to spotlight your incredible work! π Join us in advancing knowledge in this vital field!β¨ @ascocancer.bsky.social @kmittalmd.bsky.social @funchainmd.bsky.social @kerryreynoldsmd.bsky.social @oncoalert.bsky.social
22.05.2025 16:23 β π 6 π 5 π¬ 0 π 0
π Got questions about #irAEs? π€ What about tumor deposits in the lung or liverβdo they heighten the risk? Recent retrospective data from hospitalized patients suggests an association π¨ jitc.bmj.com/content/13/5... #ASPIRE @aspire-cop.bsky.social @kerryreynoldsmd.bsky.social @funchainmd.bsky.social
20.05.2025 23:52 β π 10 π 5 π¬ 2 π 0
π£ #ESMOFellowship: Check out the practical tips from Teresa Amaral and Evandro de Azambuja on how to make your application stand out.
π
Apply by 29 May 2025 at 12.00 AM CEST
π ow.ly/ANRS50VVret
20.05.2025 08:42 β π 4 π 4 π¬ 0 π 0
Blessed to have mentors who are the driving force of lung cancer research in New Zealand @anmwongnz.bsky.social & Laird Cameron.
#NewZealand #LCSM #Oncsky
05.05.2025 14:43 β π 3 π 1 π¬ 0 π 0
a cartoon of snoopy dancing with the words yay in red
ALT: a cartoon of snoopy dancing with the words yay in red
This only made possible by our funders π and lung fellow extraordinaire @mathewgwilson.bsky.social hard work to get AKL activated β€οΈβ€οΈβ€οΈ
05.05.2025 05:08 β π 1 π 0 π¬ 0 π 0
Super proud of our team Drs Laird Cameron, Sandra Fitzgerald getting our 1st Auckland patient into our FAST π« 𧬠ctDNA study today π€©π€©π€©
Laird & I first dreamed up the study while at @myesmo.bsky.social Asia Singapore Dec22!!!
Good things take time β€οΈ so fun to do research w one of my besties!
05.05.2025 05:08 β π 1 π 0 π¬ 1 π 1
Early bird registrations are open for TOGA's 2025 ASM!
The theme of this yearβs hybrid event is βImplementing Change in Thoracic Cancer Care Through Multidisciplinary Innovationβ, with a special focus on bringing evidence-based solutions into practice using implementation science.
01.05.2025 05:59 β π 1 π 1 π¬ 1 π 0
Beyond excited about Pharmacβs proposed melanoma drug funding from 1st June!
πππAlex van Akkooi @melanomaau.bsky.social & Hannah Farnsworth @petermaccc.bsky.social for sharing their surgical and nursing experience in Melnetβs virtual session on perioperative melanoma management next Tuesday.
30.04.2025 09:49 β π 0 π 0 π¬ 1 π 0
Get ready to hear from Kelvin Lau, presenting onΒ Robot Assisted Endobronchial Intervention at the 2025 TOGA ASM!
Don't miss this chance to hear from leading experts.
π
Save the date: July 30 β August 1
π Location: Brisbane Convention & Exhibition Centre
Check out the program > buff.ly/7YecVX1
29.04.2025 02:05 β π 1 π 1 π¬ 0 π 0
Felt so honoured to be gifted this MΔori taonga (treasure) after an uplifting day at the marae: learning with our community cancer navigators & our cancer support team!
A sacred symbol of our collaboration, united together for our patients & whanau β€οΈ
πTY for invite!
#maoriculture #oncology #MedEd
29.04.2025 07:15 β π 2 π 0 π¬ 0 π 0
So interesting!
23.04.2025 22:46 β π 1 π 0 π¬ 0 π 0
Treatment De-escalation for Favorable Risk Breast Cancer | Podcast | ASCO Publications
Dr. Chino talks with Dr. Atif Khan and Dr. Lola Fayanju about the shift in breast cancer management from reducing locoregional recurrence and improving breast cancer mortality to deintensification, sh...
ποΈIt's not one size fits all with cancer care. We're trying to make a customized plan & [rally] all of the modern technologies to make sure that we're rightsizing the treatments for the individual.
And I think that provides a lot of benefits for patients.
#breastCancer #bcsm
@ascocancer.bsky.social
23.04.2025 18:26 β π 19 π 2 π¬ 0 π 0
Program Guide β ASCO Meeting Program Guide
NIVOPOSTOP (GORTEC 2018-01): Ph3 RCT of adjuvant nivolumab added to radio-chemotherapy in Pts w/ resected head & neck squamous cell carcinoma at high risk of relapse - Bourhis et al. #ASCO25 LBA2 meetings.asco.org/abstracts-pr... #NCT03576417 #hncsm #ImmunoOnc
23.04.2025 19:20 β π 2 π 1 π¬ 0 π 1
β°Less than 2 weeks left to submit your abstract to #ESMOTATAsia25! A fantastic opportunity to showcase your transformative work within the region in a truly international platform.
πSubmit your research by 29 April by 18:00 Hong Kong Time
π buff.ly/nOD4Kzs
16.04.2025 06:15 β π 6 π 2 π¬ 0 π 0
Bipartisan bill seeks to reform prior authorization @thehill.com @ascocancer.bsky.social thehill.com/policy/healt...
28.03.2025 13:05 β π 2 π 1 π¬ 0 π 0
Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We're grateful for their extraordinary commitment. asco.org/about-asco/a...
@adesaimd.bsky.social @pgrivasmdphd.bsky.social @sagarlonialmd.bsky.social @pateloncology.bsky.social
28.03.2025 14:04 β π 14 π 5 π¬ 2 π 3
Huge news for patients in nz with melanoma!
Government funding for:
π€©perioperative Pembrolizumab for resectable stage III
π€©Dabrafenib and Trametinib adjuvant and metastatic setting
20.03.2025 00:59 β π 3 π 0 π¬ 0 π 0
YouTube video by European Society for Medical Oncology (ESMO)
Diary of an oncology leader: Episode 1 β Solange Peters
What an inspiring video to wake up to!
πfind strength in your team
πdefend what is right
πyou can do ANYTHING but not everything
πfight imposter syndrome - you deserve to be there
youtu.be/i6fe2EK2lh8?...
@solangepeters.bsky.social
@drjnaidoo.bsky.social
#ESMO #Women4Oncology #oncology
12.03.2025 09:36 β π 11 π 5 π¬ 0 π 0
9.5% MET and 7.9% EGFR detected in pts w lung SqCC with no smoking history.
Important to improve testing in this group. We are finding more of this with reflex testing in early stage disease.
#lcsm
19.01.2025 16:48 β π 9 π 4 π¬ 1 π 0
Global Healthcare Services Manager @ Hyland | Passionate about healthcare, digital health, AI & cloud | BSc, PRINCE2, MSP, L6Ο Green Belt | Opinions are my own | https://linktr.ee/paulcochrane
Lung Cancer Patient Research Advocate | Chair of the TRACKER Lung Cancer Biobank Consumer Committee | Deputy Chair of ALK Positive Australia | Rare Cancers Australia PAB | Diagnosed Stage IV Lung Cancer - 2014 at age 32 | On a mission to drive change! π«ποΈβ€οΈπ
Oncologist & Clinical Researcher @MassGeneralCancerCenter | Director, Severe Immunotherapy Complications (SIC) Service | Focused on immune-related adverse events (irAEs), advancing care, research, and cross-disciplinary collaboration #ASPIRE #irAE #ASCO25
GU medical oncologist. Cleveland Clinic alum. Views my own.
It takes a village! Join our Community of Practice in uniting the global medical community to enhance care, education, research, and advocacy for immune-related adverse events #irAE for people living with cancer #ASPIRE #ASCO25
The European Society for Medical Oncology (ESMO) is a reference organisation for cancer education and information, supporting the oncology communityβs work.
Medical Oncologist w/ interests in #lungcancer, #sarcoma & #drugdevelopment | Associate Professor, Department of Clinical Oncology & Deputy Medical Director, Phase 1 Clinical Trials Centre, CUHK
EMPOWERING LUNG CANCER BREAKTHROUGHS
π High-quality biospecimens & data
π Global collaborations
π¬ Discovering new treatments
π www.trackerbiobank.com
The leading thoracic cancer clinical trials group in Australia and New Zealand
News and views from the world of clinical oncology and hematology
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology.
The worldβs leading professional organization representing more than 50,000 oncology professionals caring for people with cancer.
Medical Oncologist, #CancerInformatics, #PrecisionOncology, #Oncology, #TranslationalInformatics, Clinical #MachineLearning and #ArtificialIntelligence
Head, Cancer Genomics Translational Research Centre
@petermaccc.bsky.social
@petermaccc.bsky.social NHMRC Emerging Leadership Fellow,
Connecting Discovery to Cancer Care
#radonc at University of Miami.
#Digitalhealth enjoyer. #digitaltransformation enthusiast.
Doesnβt have a podcast.
#FosterCare alum #GIonc #pallonc #survonc doc at Parkview Health #supponc #hpm #hapc. Uniting support and cancer care. Ft Wayne IN. GI Med Oncologist/Palliative Medicine Physician
Residente OncologΓa MΓ©dica π©πΌββοΈ Hospital Universitario 12 de Octubre
Director, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Kohberg Professor of Medicine, Harvard Medical School
Physician-scientist dermatopathologist studying melanoma metastasis. Clinical instructor and postdoctoral fellow at Rockefeller University in the Tavazoie Lab; Research fellow in the dermatopathology division at MSKCC.
